#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14722	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2149	817.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1451	1451	C	966	C,T	965,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14722	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2149	817.6	0	HET	.	.	.	C611T,G	.	611	611	C	878	878	C	881	C,T,G	641,238,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24052	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3900	768.1	0	.	n	.	0	T695C	SNP	695	695	T	1189	1189	C	916	C,G	915,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24052	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3900	768.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1831	1831	A	948	A	948	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24052	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3900	768.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2465	2465	C	855	C,A	853,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24052	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3900	768.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3091	3091	T	831	T,G	829,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24052	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3900	768.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2539	2539	A	742	A,T,C	740,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2200	folP	852	852	100.0	folP.l15.c4.ctg.1	2000	136.7	1	SNP	p	R228S	1	.	.	682	684	AGC	1184	1186	AGC	241;237;237	A,G,C;G;C	238,1,1;237;237	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5810	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3781	191.3	1	SNP	p	S91F	0	.	.	271	273	TCC	788	790	TCC	212;214;216	T;C;C	212;214;216	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5810	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3781	191.3	1	SNP	p	D95N	0	.	.	283	285	GAC	800	802	GAC	226;228;229	G;A;C	226;228;229	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5810	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3781	191.3	1	SNP	p	D95G	0	.	.	283	285	GAC	800	802	GAC	226;228;229	G;A;C	226;228;229	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	2096	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1790	145.9	1	SNP	p	G45D	1	.	.	133	135	GAC	662	664	GAC	247;247;246	G,A;A,C;C	246,1;246,1;246	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1228	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1534	99.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5362	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3322	201.3	1	SNP	p	D86N	0	.	.	256	258	GAC	776	778	GAC	230;232;227	G;A,C;C,A	230;231,1;226,1	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5362	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3322	201.3	1	SNP	p	S87R	0	.	.	259	261	AGT	779	781	AGT	228;226;224	A,C;G;T	227,1;226;224	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5362	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3322	201.3	1	SNP	p	S87I	0	.	.	259	261	AGT	779	781	AGT	228;226;224	A,C;G;T	227,1;226;224	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5362	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3322	201.3	1	SNP	p	S87W	0	.	.	259	261	AGT	779	781	AGT	228;226;224	A,C;G;T	227,1;226;224	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5362	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3322	201.3	1	SNP	p	S88P	0	.	.	262	264	TCC	782	784	TCC	225;225;226	T;C;C	225;225;226	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4506	parE	1986	1986	100.0	parE.l15.c17.ctg.1	3049	184.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1779	1781	GGC	247;245;246	G;G;C	247;245;246	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4074	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2934	173.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1548	1550	GCA	228;228;226	G,T,A;C;A,G	226,1,1;228;225,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4074	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2934	173.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1551	1553	ATC	227;227;228	A;T,C;C	227;226,1;228	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4074	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2934	173.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1563	1565	GTG	228;230;233	G,T;T;G	227,1;230;233	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4074	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2934	173.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1563	1565	GTG	228;230;233	G,T;T;G	227,1;230;233	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4074	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2934	173.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2067	2069	ACC	193;193;193	A;C;C	193;193;193	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4074	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2934	173.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2121	2123	GCG	208;207;210	G;C;G,T,A	208;207;208,1,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4074	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2934	173.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2121	2123	GCG	208;207;210	G;C;G,T,A	208;207;208,1,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4074	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2934	173.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2244	2246	GGC	219;220;219	G,T;G,A,T;C	217,2;217,2,1;219	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4074	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2934	173.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2253	2255	GGC	220;221;221	G;G,T;C,A	220;220,1;220,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4074	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2934	173.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2271	2273	CCG	211;212;214	C,G,T;C,T;G,T	208,2,1;211,1;212,2	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5598	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3450	201.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1764	1766	CTG	232;234;232	C;T,G,C;G,T	232;232,1,1;231,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2708	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2404	140.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	862	862	C	207	C,A	206,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2676	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1667	195.3	0	.	p	.	0	I45V	NONSYN	133	135	ATT	614	616	GTT	244;243;246	G;T;T,G	244;243;245,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2676	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1667	195.3	0	.	p	.	0	N121S	NONSYN	361	363	AAC	842	844	AGC	208;207;204	A;G,C;C	208;206,1;204	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2676	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1667	195.3	0	.	p	.	0	N122K	NONSYN	364	366	AAC	845	847	AAA	201;201;202	A,C;A,C;A,G	200,1;200,1;201,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2676	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1667	195.3	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	908	910	GAA	209;210;210	G;A,G;A	209;209,1;210	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2676	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1667	195.3	0	.	p	.	0	V151A	NONSYN	451	453	GTA	932	934	GCA	216;217;210	G,A;C;A,G	215,1;217;209,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2676	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1667	195.3	0	.	p	.	0	K207_M208insK	INS	619	619	A	1100	1100	A	278	A	277	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2676	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1667	195.3	0	.	p	.	0	A212S	NONSYN	634	636	GCA	1118	1120	TCA	265;266;264	T,C,A;C,A;A,C	263,1,1;264,2;263,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2676	porB1b	1038	1038	97.23	porB1b.l15.c30.ctg.1	1667	195.3	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1235	1235	T	198	T	198	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	234	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	48.8	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	64;64;64	A;C;T	64;64;64	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	234	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	48.8	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	64;64;64	A;G;T	64;64;64	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	234	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	48.8	0	.	p	.	0	K278D	NONSYN	832	834	AAA	77	79	GAC	64;64;64	G;A;C	64;64;64	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	234	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	48.8	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	80	82	TAC	64;64;64	T;A;C	64;64;64	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9166	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5287	216.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2175	2177	AAT	249;247;248	A,C;A;T,G	248,1;247;247,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1376	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1426	120.1	1	SNP	p	V57M	1	.	.	169	171	ATG	704	706	ATG	255;255;252	A;T;G	255;255;252	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
